Lexeo Therapeutics (LXEO) Net Income: 2022-2023
Historic Net Income for Lexeo Therapeutics (LXEO) over the last 1 years, with Dec 2023 value amounting to -$14.2 million.
- Lexeo Therapeutics' Net Income rose 2.68% to -$14.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$66.4 million, marking a year-over-year change of. This contributed to the annual value of -$98.3 million for FY2024, which is 48.11% down from last year.
- Per Lexeo Therapeutics' latest filing, its Net Income stood at -$14.2 million for Q4 2023, which was up 29.45% from -$20.1 million recorded in Q3 2023.
- Lexeo Therapeutics' 5-year Net Income high stood at -$13.4 million for Q2 2023, and its period low was -$20.1 million during Q3 2023.
- In the last 2 years, Lexeo Therapeutics' Net Income had a median value of -$15.8 million in 2022 and averaged -$16.3 million.
- Data for Lexeo Therapeutics' Net Income shows a peak YoY increase of 2.68% (in 2023) and a maximum YoY decrease of 17.90% (in 2023) over the last 5 years.
- Quarterly analysis of 2 years shows Lexeo Therapeutics' Net Income stood at -$14.6 million in 2022, then rose by 2.68% to -$14.2 million in 2023.
- Its Net Income was -$14.2 million in Q4 2023, compared to -$20.1 million in Q3 2023 and -$13.4 million in Q2 2023.